Skip to content
Drug recall · FDA · Published February 20, 2024

Contract Pharmaceuticals Limited Canada recalls Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex

Marlex recalls 1% Clindamycin Phosphate Topical Solution due to potential container leakage affecting stability. Discard or return affected lots before expiration.

🇺🇸 FDA recall #D-0364-2024DrugMarlex ›
Take action

Contact the company & request your remedy

Recalling firmContract Pharmaceuticals Limited Canada7600 East Danbro Cres · Mississauga, N/A
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Marlex is recalling 1% Clindamycin Phosphate Topical Solution (Rx only) because the container may leak over time, risking product instability. This could lead to ineffective treatment if used after the expiration date. Read more at govinfonow.com/recall/32802-marlex-clindamycin-phosphate-topical-solution-recall-container-leakage-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32802-marlex-clindamycin-phosphate-topical-solution-recall-container-leakage-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0364-2024

Cite this page

“Marlex Clindamycin Phosphate Topical Solution Recall: Container Leakage Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32802-marlex-clindamycin-phosphate-topical-solution-recall-container-leakage-risk. Based on FDA recall #D-0364-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0364-2024%22&limit=1).

Why it’s dangerous

The container may leak slowly over time, especially after 12 months of storage. This leakage could cause the medication to become unstable, potentially reducing its effectiveness before the expiration date.

Who’s affected

Prescription users of the 1% Clindamycin Phosphate Topical Solution who received the recalled lots (NDC 10135-0691-61) from Marlex. Patients with skin infections requiring this medication are most at risk.

How to tell if you have this one

Check the product label for the NDC code 10135-0691-61. The recalled lots have specific expiration dates: 04/2025, 08/2025, and 11/2025. The product is only available by prescription.

  • Brand
    Marlex
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Ongoing
  • Distribution
    Nationwide in the U.S. and Puerto Rico
Recall numberProduct, codes & lotsQuantity
D-0364-2024Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61; Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/202545,875 bottles
D-0365-2024Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60; Lot #: 119874; Exp 06/30/202511,750 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC code 10135-0691-61 on the container.

  2. Discard Recalled Product

    If you have the recalled lots, discard them immediately to avoid potential instability.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may become unstable due to slow leakage, so it is not recommended for use after the expiration date.

How do I know if I have the recalled product?

Check the product label for the NDC code 10135-0691-61 and the specific expiration dates: 04/2025, 08/2025, or 11/2025.

What should I do if I have the recalled product?

Discard the product immediately to avoid potential instability.

Take action

Contact Marlex

We’ve drafted a message you can send Marlex to request your refund or repair — edit it as you like.

Subject: Recall D-0364-2024 — Marlex Marlex

Hello,

I own a Marlex that is covered by recall D-0364-2024 from Marlex.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0364-2024 (February 20, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0364-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA